BRIEF published on 02/27/2025 at 05:05, 9 months 6 days ago Adtran Networks SE Announces Q4 and FY 2024 Financial Results EBIT Loss Gross Margin Improvement Q4 2024 Revenues Annual Revenue Decline Financial Statements Publication
PRESS RELEASE published on 02/27/2025 at 05:00, 9 months 6 days ago Adtran Networks SE announces preliminary results for Q4 2024 and fiscal year 2024 Adtran Networks SE announces preliminary results for Q4 2024 and fiscal year 2024 with a 0.4% increase in Q4 2024 revenues and a full-year revenue decrease of 28.6% in 2024 Preliminary Results Fiscal Year 2024 Revenue Decrease Adtran Networks SE Q4 2024
BRIEF published on 11/07/2024 at 07:00, 1 year ago Adtran Networks SE Reports Q3 2024 Financial Results Revenue Decline Net Loss Cash Flow Improvement Future Outlook Q3 2024 Financial Results
PRESS RELEASE published on 11/07/2024 at 06:55, 1 year ago Adtran Networks SE announces results for Q3 2024 Adtran Networks SE announces Q3 2024 results with decrease in revenue and net loss. Operating loss attributed to lower revenues. Anticipates improved demand in mid-term Revenue Decrease Net Loss Adtran Networks SE Operating Loss Q3 2024 Results
BRIEF published on 08/06/2024 at 05:05, 1 year 3 months ago Adtran Networks SE Announces Results for Q2 2024 Financial Performance Revenue Decline Net Loss Adtran Networks Q2 2024 Results
PRESS RELEASE published on 08/06/2024 at 05:00, 1 year 3 months ago Adtran Networks SE announces results for Q2 2024 Adtran Networks SE reports Q2 2024 financial results with decrease in revenues and pro forma EBIT, but improvement in operating loss. Company remains optimistic about mid-term prospects amid challenging market conditions Revenues Financial Results Q2 2024 Adtran Networks SE Operating Efficiency
BRIEF published on 05/07/2024 at 06:05, 1 year 6 months ago Adtran Networks SE Reports Q1 2024 Financial Results Financial Results Revenue Decline Q1 2024 Operating Loss Adtran Networks
PRESS RELEASE published on 05/07/2024 at 06:00, 1 year 6 months ago Adtran Networks SE announces results for Q1 2024 Adtran Networks SE announces Q1 2024 results with EUR 109.6 million in revenues and negative EUR 3.4 million pro forma EBIT, impacted by macroeconomic environment Revenues Macroeconomic Environment Adtran Networks SE Q1 2024 Results Pro Forma EBIT
PRESS RELEASE published on 02/27/2024 at 06:11, 1 year 9 months ago EQS-Adhoc: Adtran Networks SE announces results for fiscal year 2023 Adtran Networks SE announces preliminary financial results for fiscal year 2023, showing a 13.8% decrease in annual revenues. The full report will be published on April 18, 2024 Revenues Financial Results Fiscal Year 2023 Adtran Networks SE Preliminary
BRIEF published on 02/27/2024 at 06:11, 1 year 9 months ago Adtran Networks SE publishes its financial results for the financial year 2023 Cost Optimization 2023 Financial Results Macroeconomic Environment Adtran Networks SE Fall In Income
Published on 12/05/2025 at 02:35, 4 hours 10 minutes ago Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 01:00, 5 hours 45 minutes ago BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 7 hours 40 minutes ago BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 7 hours 45 minutes ago NXT Energy Solutions Completes Data Acquisition for SFD Survey
Published on 12/05/2025 at 03:30, 3 hours 15 minutes ago CGTN: What makes cooperation between China and France a two-way success
Published on 12/04/2025 at 23:50, 6 hours 55 minutes ago EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes
Published on 12/04/2025 at 20:25, 10 hours 20 minutes ago Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions
Published on 12/04/2025 at 20:15, 10 hours 30 minutes ago Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025
Published on 12/04/2025 at 19:10, 11 hours 35 minutes ago SCHOTT Pharma’s preliminary results for fiscal year 2025; outlook for FY 2026 and update of mid-term guidance
Published on 12/04/2025 at 18:00, 12 hours 45 minutes ago Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 13 hours ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 13 hours 1 minute ago Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution
Published on 12/04/2025 at 07:01, 23 hours 44 minutes ago bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health
Published on 12/03/2025 at 18:00, 1 day 12 hours ago Declaration of voting rights at the end of November 2025
